Innovation Fellow (Senior Director)
Pfizer
June 25, 2026
Remote friendly (Cambridge, MA)
United States
Other
Role Responsibilities:
- Partner with IM leadership to accelerate CMD-specific drug discovery by leveraging entrepreneurial and scientific advice, funding, and space.
- Identify, implement, and manage high-profile collaborative and incubator partnerships to integrate AI-driven strategies into cardiometabolic drug candidate discovery and development.
- Represent IM to external collaboration partners and build relationships with academic, biopharma, and entrepreneur stakeholders to advance AI applications in cardiometabolic drug discovery.
- Establish oversight and metrics for a portfolio of collaborative projects to measure success and value generation.
- Serve as an interface between IM, Business Development (BD), Legal, Discovery Network, and other supporting functions to navigate collaborations and maximize ROI.
- Manage collaboration and partnership risks and implement mitigation strategies.
- Communicate progress to senior leaders and secure resources (budget and FTEs) to deliver the collaboration plan.
Basic Qualifications:
- Strong experience leading drug discovery programs and/or developing and applying AI capabilities for drug discovery.
- PhD or MD with at least 15 years in relevant Internal Medicine-based scientific disciplines.
- Broad understanding of cardiometabolic disease biology.
- Contemporary knowledge of AI for drug discovery.
- Track record managing results from complex academic–industry alliances.
- Experience developing milestone-based collaborative research plans.
- Ability to facilitate complex strategic discussions; strong leadership and presentation skills.
Preferred Qualifications:
- Experience with multidisciplinary teams in collaborative environments.
- Entrepreneurial thinking and strong organizational skills.
- Success negotiating in highly matrix-based organizations.
Work Location Assignment:
- Hybrid; live within commuting distance and work on-site ~2.5 days/week.
- Partner with IM leadership to accelerate CMD-specific drug discovery by leveraging entrepreneurial and scientific advice, funding, and space.
- Identify, implement, and manage high-profile collaborative and incubator partnerships to integrate AI-driven strategies into cardiometabolic drug candidate discovery and development.
- Represent IM to external collaboration partners and build relationships with academic, biopharma, and entrepreneur stakeholders to advance AI applications in cardiometabolic drug discovery.
- Establish oversight and metrics for a portfolio of collaborative projects to measure success and value generation.
- Serve as an interface between IM, Business Development (BD), Legal, Discovery Network, and other supporting functions to navigate collaborations and maximize ROI.
- Manage collaboration and partnership risks and implement mitigation strategies.
- Communicate progress to senior leaders and secure resources (budget and FTEs) to deliver the collaboration plan.
Basic Qualifications:
- Strong experience leading drug discovery programs and/or developing and applying AI capabilities for drug discovery.
- PhD or MD with at least 15 years in relevant Internal Medicine-based scientific disciplines.
- Broad understanding of cardiometabolic disease biology.
- Contemporary knowledge of AI for drug discovery.
- Track record managing results from complex academic–industry alliances.
- Experience developing milestone-based collaborative research plans.
- Ability to facilitate complex strategic discussions; strong leadership and presentation skills.
Preferred Qualifications:
- Experience with multidisciplinary teams in collaborative environments.
- Entrepreneurial thinking and strong organizational skills.
- Success negotiating in highly matrix-based organizations.
Work Location Assignment:
- Hybrid; live within commuting distance and work on-site ~2.5 days/week.